Brief: Lipum Completes Phase I Study With Sol-116

Lipum AB (publ)

25/02/2025 09:11

Feb 25 (Reuters) - Lipum AB (publ)  LIPUM.ST :
    * HAS SUCCESSFULLY COMPLETED PHASE I STUDY WITH SOL-116
    * STUDY CONFIRMED SOL-116'S FAVOURABLE SAFETY, TOLERABILITY,
AND
PREDICTABLE PHARMACOKINETICS, SUPPORTING A ONCE-MONTHLY DOSING
REGIMEN

Source text:  ID:nMFN4pKQ4B 
Further company coverage:  LIPUM.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))